Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
Fenix Farmaci AB
AB
Active
Org 5568257561
Skogsliden 27, 187 41
Täby
Educational support activities n.e.c.
·
NACE 8569
Est. 2010 · 15 years old
0 employees
Monitor
Share
Sweden
/
Companies
/
Educational support activities n.e.c.
/
Fenix Farmaci AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
0M
0M
0M
-1M
-1M
2021: 0M
0M
2021
2022: 0M
0M
2022
2023: 0M
0M
2023
2024: 0M
0M
2024
2025: 0M
0M
2025
EBITDA
SEK millions
0M
0M
0M
-1M
-1M
2021: 0M
0M
2021
2022: 0M
0M
2022
2023: 0M
0M
2023
2024: 0M
0M
2024
2025: 0M
0M
2025
Income statement
SEK thousands
Item
2025
2024
2023
2022
2021
Revenue
0
−0
0
0
0
Staff expenses
−0
−0
−0
−0
—
EBITDA
79
1
−9
−6
−17
Depreciation & amort.
—
—
—
—
−0
EBIT
79
1
−9
−6
−17
Net financials
110
0
42
0
—
Profit before tax
189
1
33
−6
−17
Tax
−39
−0
−2
—
−0
Net profit
150
1
31
−6
−17
Balance sheet
SEK thousands
Item
2025
2024
2023
2022
2021
Total assets
343
601
680
687
1 406
Equity
294
144
142
112
118
Long-term debt
—
—
—
—
0
Short-term debt
49
457
538
576
1 288
Total debt
49
457
538
576
1 288
Financial ratios
5-year trend
EBITDA margin
>999 %
This company
15,8 %
Market median
This company
Market median
>999% above market
2021
2025
Equity ratio
85,6 %
This company
38,2 %
Market median
This company
Market median
124% above market
2021
2025
Return on equity
51,1 %
This company
18,4 %
Market median
This company
Market median
178% above market
2021
2025
Net profit margin
>999 %
This company
8,1 %
Market median
This company
Market median
>999% above market
2021
2025
Asset turnover
0,00×
This company
1,12×
Market median
This company
Market median
100% below market
2021
2025
Debt / equity
0,17×
This company
0,62×
Market median
This company
Market median
73% below market
2021
2025
Annual reports & filings
Annual report 2025
Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
View
PDF
More on Fenix Farmaci AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
